Search Non-Antibody Products
|
|
|
|
|
Non-antibody Products (Kits, Proteins, Microbial Antigens, Tissues, Services, etc.) - Page 9 of 5,777
| Name |
Description |
Size |
Catalog # |
Supplier |
|
| AG 490 |
Minimum Purity: > 99%. Selective inhibitor of EGF receptor tyrosine kinase (IC50 values are 2 and 13.5 µM for EGFR and ErbB2 respectively). Inhibitor of JAK2, JAK3/STAT, JAK3/AP-1 and JAK3/MAPK pathways and potently inhibits cytokine-indepen... |
10mg |
414 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 490 |
Minimum Purity: > 99%. Selective inhibitor of EGF receptor tyrosine kinase (IC50 values are 2 and 13.5 µM for EGFR and ErbB2 respectively). Inhibitor of JAK2, JAK3/STAT, JAK3/AP-1 and JAK3/MAPK pathways and potently inhibits cytokine-indepen... |
50mg |
414 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 555 |
Minimum Purity: > 99%. Potent epidermal growth factor receptor (EGFR) kinase inhibitor (IC50 = 0.7 µM) that displays 50-fold and >140-fold selectivity over ErbB2 and insulin receptor kinase respectively. Induce G1 growth arrest selectively i... |
10mg |
618 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 555 |
Minimum Purity: > 99%. Potent epidermal growth factor receptor (EGFR) kinase inhibitor (IC50 = 0.7 µM) that displays 50-fold and >140-fold selectivity over ErbB2 and insulin receptor kinase respectively. Induce G1 growth arrest selectively i... |
50mg |
618 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 556 |
Minimum Purity: > 99%. Epidermal growth factor receptor (EGFR) kinase inhibitor (IC50 = 1.1 µM). Selective over ErbB2 (IC50 > 500 µM). |
10mg |
616 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 556 |
Minimum Purity: > 99%. Epidermal growth factor receptor (EGFR) kinase inhibitor (IC50 = 1.1 µM). Selective over ErbB2 (IC50 > 500 µM). |
50mg |
616 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 825 |
Minimum Purity: > 98%. Selective ErbB2 inhibitor (IC50 values are 0.15 and 19 mM at ErbB2 and ErbB1 respectively). Preferentially triggers p38 MAP kinase-dependent apoptosis in androgen-independent prostate cancer cells. |
10mg |
1555 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 825 |
Minimum Purity: > 98%. Selective ErbB2 inhibitor (IC50 values are 0.15 and 19 mM at ErbB2 and ErbB1 respectively). Preferentially triggers p38 MAP kinase-dependent apoptosis in androgen-independent prostate cancer cells. |
50mg |
1555 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 879 |
Minimum Purity: > 99%. Inhibitor of the tyrosine kinase activity of nerve growth factor (NGF) TrkA. Decreases cellular proliferation in human muscular sarcoma cell lines. Also inhibits ErbB2 and VEGFR-2 (IC50 values are approximately 1 µM fo... |
10mg |
2617 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 99 |
Minimum Purity: > 99%. Epidermal growth factor receptor (EGFR) kinase inhibitor (IC50 = 10 µM) that is selective over insulin receptor kinase. Blocks tyrosine phosphorylation of p145met and promotes cell death of normal and cancer cells via ... |
10mg |
497 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 99 |
Minimum Purity: > 99%. Epidermal growth factor receptor (EGFR) kinase inhibitor (IC50 = 10 µM) that is selective over insulin receptor kinase. Blocks tyrosine phosphorylation of p145met and promotes cell death of normal and cancer cells via ... |
50mg |
497 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 494 |
Minimum Purity: > 98%. Potent inhibitor of epidermal growth factor receptor (EGFR) kinase (IC50 = 0.7 µM). Selective over ErbB2, PDGFR and insulin receptor kinase (IC50 values are 42, 6 and > 100 µM respectively). |
10mg |
619 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 494 |
Minimum Purity: > 98%. Potent inhibitor of epidermal growth factor receptor (EGFR) kinase (IC50 = 0.7 µM). Selective over ErbB2, PDGFR and insulin receptor kinase (IC50 values are 42, 6 and > 100 µM respectively). |
50mg |
619 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 045572 |
Minimum Purity: > 98%. Selective gonadotropin-releasing hormone (GnRH) receptor antagonist (Ki values are 2.2, 3.8 and 6.0 nM for mouse, rat and human receptors respectively). Suppresses testosterone and luteinising hormone (LH) levels in vivo. |
1mg |
2730 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG 045572 |
Minimum Purity: > 98%. Selective gonadotropin-releasing hormone (GnRH) receptor antagonist (Ki values are 2.2, 3.8 and 6.0 nM for mouse, rat and human receptors respectively). Suppresses testosterone and luteinising hormone (LH) levels in vivo. |
10mg |
2730 |
 TOCRIS BIOSCIENCE |
More Info
|
| AG-014699 |
AG-014699 is a PARP inhibitor (Ki, 1.4 nmol/L). Purity is greater than 99%. |
5 mg |
orb60138 |
 BIORBYT LTD. |
More Info
|
| AG14361 |
AG14361 is a potent poly(ADP-ribose) polymerase (PARP-1) inhibitor with a GI50 of 10.9 ?M. Purity is greater than 99%. |
10 mg |
orb60811 |
 BIORBYT LTD. |
More Info
|
| AG-490 |
AG 490 is a potent epidermal growth factor receptor kinase autophosphorylation inhibitor with an IC50 of 100 nM and 56.8 ?M for EGFR and JAK, respectively. Purity is greater than 99%. |
25 mg |
orb60171 |
 BIORBYT LTD. |
More Info
|
| AG 1478 |
Cell-permeable. A potent EGFR Tyrosine Kinase (TK) inhibitor with an IC50 of 3 nM. Only weakly inhibits PDGFR and HER2-NEU kinases (IC50 >100 µM). |
5 mg |
1800-5 |
 BIOVISION, INC. |
More Info
|
| AG 1478 |
Cell-permeable. A potent EGFR Tyrosine Kinase (TK) inhibitor with an IC50 of 3 nM. Only weakly inhibits PDGFR and HER2-NEU kinases (IC50 >100 µM). |
25 mg |
1800-25 |
 BIOVISION, INC. |
More Info
|
| AG 045572 |
GnRH Receptor Antagonist |
1 mg |
2730/1 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 045572 |
GnRH Receptor Antagonist |
10 mg |
2730/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 18 |
EGF Receptor Inhibitor |
10 mg |
0493/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 18 |
EGF Receptor Inhibitor |
50 mg |
0493/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 213 |
EGF Receptor Inhibitor |
10 mg |
0503/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 213 |
EGF Receptor Inhibitor |
50 mg |
0503/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 490 |
EGF Receptor Inhibitor |
10 mg |
0414/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 490 |
EGF Receptor Inhibitor |
50 mg |
0414/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 494 |
EGF Receptor Inhibitor |
10 mg |
0619/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 494 |
EGF Receptor Inhibitor |
50 mg |
0619/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 555 |
EGF Receptor Inhibitor |
10 mg |
0618/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 555 |
EGF Receptor Inhibitor |
50 mg |
0618/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 556 |
EGF Receptor Inhibitor |
10 mg |
0616/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 556 |
EGF Receptor Inhibitor |
50 mg |
0616/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 825 |
EGF Receptor Inhibitor |
10 mg |
1555/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 825 |
EGF Receptor Inhibitor |
50 mg |
1555/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 879 |
Trk Receptor Inhibitor |
10 mg |
2617/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 99 |
EGF Receptor Inhibitor |
10 mg |
0497/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AG 99 |
EGF Receptor Inhibitor |
50 mg |
0497/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AGAR |
n/a |
n/a |
n/a |
AMERICAN BIOANALYTICAL |
More Info
|
| Agar |
Calbiochem® brand product. |
1kg |
12177 |
 EMD MILLIPORE |
More Info
|
| Agarase |
Agarase cleaves agarose to neoagaro-oligosaccharides , and is used for quantitative, gentle recovery of DNA from low melting point agarose. |
500 units |
9201-500 |
 BIOVISION, INC. |
More Info
|
| AGK 2 |
Minimum Purity: > 98%. Selective inhibitor of SIRT2 (IC50 = 3.5 µM). Displays no activity at SIRT1 and SIRT3 at concentrations up to 40 µM. Reduces alpha-synuclein-mediated toxicity in in vitro and in vivo models of Parkinson's disease. |
10mg |
3233 |
 TOCRIS BIOSCIENCE |
More Info
|
| AGK 2 |
Minimum Purity: > 98%. Selective inhibitor of SIRT2 (IC50 = 3.5 µM). Displays no activity at SIRT1 and SIRT3 at concentrations up to 40 µM. Reduces alpha-synuclein-mediated toxicity in in vitro and in vivo models of Parkinson's disease. |
50mg |
3233 |
 TOCRIS BIOSCIENCE |
More Info
|
| AGK 2 |
Sir2-like Family Deacetylase Inhibitor |
10 mg |
3233/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AGK 2 |
Sir2-like Family Deacetylase Inhibitor |
50 mg |
3233/50 |
 R&D SYSTEMS, INC. |
More Info
|
| Agomelatine |
Agomelatine is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. Purity is greater than 99%. |
10 mg |
orb60262 |
 BIORBYT LTD. |
More Info
|
| AGR2 |
Recombinant Human Anterior Gradient Protein 2 Homolog |
10µg, 50µg, 1mg |
PRO- 580 |
 PROSPEC-TANY TECHNOGENE LTD. |
More Info
|
| AGRP |
Recombinant Human Agouti-Related Protein |
2µg, 10µg, 1mg |
HOR- 283 |
 PROSPEC-TANY TECHNOGENE LTD. |
More Info
|
| AH 6809 |
Minimum Purity: > 99%. Antagonist at prostaglandin EP1 (pA2 = 6.8) and EP2 (Ki = 350 nM) receptors. Also weakly inhibits DP receptors (pA2 = 4.45). |
50mg |
671 |
 TOCRIS BIOSCIENCE |
More Info
|
Search Non-Antibody Products
|